Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005 Apr;79(7):4440-50.
doi: 10.1128/JVI.79.7.4440-4450.2005.

Roles of the Ras-MEK-mitogen-activated protein kinase and phosphatidylinositol 3-kinase-Akt-mTOR pathways in Jaagsiekte sheep retrovirus-induced transformation of rodent fibroblast and epithelial cell lines

Affiliations

Roles of the Ras-MEK-mitogen-activated protein kinase and phosphatidylinositol 3-kinase-Akt-mTOR pathways in Jaagsiekte sheep retrovirus-induced transformation of rodent fibroblast and epithelial cell lines

Naoyoshi Maeda et al. J Virol. 2005 Apr.

Abstract

Jaagsiekte sheep retrovirus (JSRV) is the causative agent of ovine pulmonary adenocarcinoma (OPA), a transmissible lung cancer of sheep. The virus can induce tumors rapidly, and we previously found that the JSRV envelope protein (Env) functions as an oncogene, because it can transform mammalian and avian fibroblast cell lines. (N. Maeda, Proc. Natl. Acad. Sci. USA 98:4449-4454, 2001). The molecular mechanisms of JSRV Env transformation are of considerable interest. Several reports suggested that the phosphatidylinositol 3-kinase/Akt pathway is important for transformation of mammalian fibroblasts but not for chicken fibroblasts. In this study, we found that Akt/mTOR is involved in JSRV transformation of mouse NIH 3T3 fibroblasts, because treatment with the mTOR inhibitor rapamycin reduced transformation. We also found that H/N-Ras inhibitor FTI-277 and MEK1/2 inhibitors PD98059 and U0126 strongly inhibited JSRV transformation of NIH 3T3 fibroblasts, suggesting that the H/N-Ras-MEK-mitogen-activated protein kinase (MAPK) p44/42 pathway is necessary for the transformation. In RK3E epithelial cells, the MEK1/2 inhibitors also eliminated transformation, but FTI-277 only partially inhibited transformation. It was noteworthy that p38 MAPK inhibitors enhanced JSRV transformation in both fibroblasts and epithelial cells. Treatment of transformed cells with p38 inhibitors both increased levels of phospho-MEK1/2 and phospho-p44/42 and induced rapid enhancement of the transformed phenotype. Immunohistochemical staining of tumor tissues from naturally and experimentally induced OPA and naturally occurring enzootic nasal adenocarcinoma revealed strong activation of MAPK p44/42 in all cases examined. However, p38 activation was not generally observed. These results indicate that signaling through two pathways (in particular, H/N-Ras-MEK-MAPK and, to a lesser extent, Akt-mTOR) is important for JSRV-induced transformation and that p38 MAPK has a negative regulatory effect on transformation, perhaps via MEK1/2 and p44/42.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Plasmids used in this study. The plasmids are described in Materials and Methods. pCMV3ΔGP expresses the JSRV envelope from a cytomegalovirus promoter. The HA tag (checkered box) and FLAG-tag (cross-hatched box) are inserted in wild-type pCMV3ΔGP at the C terminus of the env reading frame.
FIG. 2.
FIG. 2.
Reversion of transformed NIH 3T3 cells treated with the H/N-Ras inhibitor FTI-277. NIH 3T3 cells transformed with pCMV3ΔGP(HA) [3T3(ΔGP(HA))] and with activated H-ras [3T3(H-ras)] were cloned by limiting dilution. Cells were serum starved for 20 to 24 h and treated with dimethyl sulfoxide (vehicle) (a, c, and e) or 5 μM FTI-277 (b, d, and f). Transformed cells were morphologically reversed by treatment with FTI-277 (b and d). Photographs were taken 7 days (a, b, c, and d) or 4 days (e and f) after treatment with FTI-277. Magnification, ×100 in all panels.
FIG. 3.
FIG. 3.
Transformation of immortalized rat kidney epithelial cells, RK3E. RK3E cells were transfected with 5 μg of (a) pcDNA3.1(−) (control), (b) v-mos, (c) H-ras, or (d) pCMV3ΔGP. Foci of transformed cells at day 14 after transfection are shown in panels b, c, and d. Magnification, ×100 in all panels.
FIG. 4.
FIG. 4.
Activation of signaling pathways in JSRV-transformed cells. (a) In vitro ERK1/2 kinase assay. Twenty-four hours after seeding, parental (lane c) and JSRV-transformed RK3E (lane d) cells were serum starved for 20 to 24 h, and cell lysates were tested in the in vitro kinase assay for ERK1/2 as described in Materials and Methods. Western blotting for the phosphorylated Elk-1 substrate is shown. Lane a, ATP-substrate mix without any enzyme added; lane b, ATP-substrate mix incubated with purified ERK protein. n.c., negative control; p.c., positive control. (b) Phosphorylation of p38 MAPK in RK3E. Twenty-four hours after seeding, parental (lane a) cells and RK3E cells transformed by pCMV3ΔGP(HA) (lane b) or by pCMV3ΔGP(FLAG) (lane c) were serum starved for 20 to 24 h, and cell lysates were subjected to Western blotting analysis with pan-p38 (lower panel) and phospho-p38 (upper panel) antibodies. (c) Phosphorylation of MEK1/2 in NIH 3T3 cells treated with p38 inhibitor. Cells were serum starved for 20 to 24 h and treated with dimethyl sulfoxide (DMSO) (vehicle) (lanes a and f), 5 μM SB203580 (lanes c and g), 10 μM SB203580 (lanes d and h), 20 μM SB203580 (lanes e and i), or 100 ng of EGF/ml (lane b) for 30 min. Cells lysates were subjected to Western blot analysis with pan-MEK1/2 (lower panel) and phospho-MEK1/2 (upper panel) antibodies. (d) Phosphorylation of ERK1/2 in NIH 3T3 cells treated with p38 inhibitor. Cells were serum starved for 20 to 24 h and treated with dimethyl sulfoxide (vehicle) (lanes a and c) or 10 μM SB203580 (lanes b and d) for 30 min. Cells lysates were subjected to Western blotting analysis with pan-ERK1/2 (lower panel) and phospho-ERK1/2 (upper panel) antibodies.
FIG. 5.
FIG. 5.
Morphological changes of cells treated with SB203580. Cells were serum starved for 20 to 24 h and treated with dimethyl sulfoxide (vehicle) (a, c, e, and g) or 10 μM SB203580 (b, d, f, and h). Morphological changes were observed only in transformed cells treated with SB203580 (b and f). Photographs were taken 24 h after treatment with SB203580. Similar morphological changes were also observed in RK3E cells transformed with FLAG-tagged JSRV Env treated with 10 μM SB203580. Magnification, ×100 in all the panels. Note the increased numbers of rounded and refractile cells in the JSRV-transformed cultures after treatment with SB203580.
FIG. 6.
FIG. 6.
Immunohistochemical staining of naturally and experimentally induced OPA and naturally induced ENA. Lung tissues were obtained from one normal lung from a young lamb with no known exposure to JSRV, three experimentally induced OPA cases, and three naturally occurring OPA cases. Also, tissues were obtained from a normal nasal mucosa and from three naturally occurring ENAs. Immunohistochemical staining was performed with antibodies against phospho-ERK1/2 (Thr202/Tyr204), phospho-p38 (Thr180/Tyr182), and phospho-SAPK/JNK (Thr183/Tyr185) as primary antibodies. The numbers in the panels indicate the numbers of lungs showing positive staining (+) out of the total number examined. If available, positively staining tissues are shown. +d indicates weak, diffuse staining. Micrographs are shown at the same magnification (×400), except for those from the experimental OPA (all stains) and the ENA (pSAPK/JNK), which were taken at a lower magnification (×100). Neg., negative.
FIG. 7.
FIG. 7.
Model of JSRV Env-induced transformation. A proposed model for signaling in JSRV Env-induced transformation is shown. JSRV envelope protein leads directly or indirectly to activation of the Ras-MEK-MAPK and PI3K-Akt-mTOR pathways as well as to activation of p38 MAPK, which negatively regulates transformation. Question marks indicate alternate pathways that are inferred from the data, but the identities of the key proteins are not known. Sizes of the arrows reflect the relative importance for transformation. The arrows do not necessarily indicate direct binding and/or activation of the downstream molecules; intermediate proteins or kinases may exist.

Similar articles

Cited by

References

    1. Alberti, A., C. Murgia, S. L. Liu, M. Mura, C. Cousens, M. Sharp, A. D. Miller, and M. Palmarini. 2002. Envelope-induced cell transformation by ovine betaretroviruses. J. Virol. 76:5387-5394. - PMC - PubMed
    1. Aoki, M., E. Blazek, and P. K. Vogt. 2001. A role of the kinase mTOR in cellular transformation induced by the oncoproteins P3k and Akt. Proc. Natl. Acad. Sci. USA 98:136-141. - PMC - PubMed
    1. Ballif, B. A., and J. Blenis. 2001. Molecular mechanisms mediating mammalian mitogen-activated kinase (MAPK) kinase (MEK)-MAPK cell survival signals. Cell Growth Differ. 12:397-408. - PubMed
    1. Bellacosa, A., J. R. Testa, S. P. Staal, and P. N. Tsichlis. 1991. A retroviral oncogene, akt, encoding a serine-threonine kinase containing an SH2-like region. Science 254:274-277. - PubMed
    1. Bellacosa, A., J. R. Testa, R. Moore, and L. Larue. 2004. A portrait of AKT kinases: human cancer and animal models depict a family with strong individualities. Cancer Biol. Ther. 3:268-275. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources